RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:213767

Squamous cell carcinoma of the cervix uteri

high confidenceDisorder

Also known as: Cervical squamous cell carcinoma

Publications

17,441

98.8th percentile

Trials

80

Interventional, condition-specific

Researchers

1,026

Distinct authors in sample

Gene link

—

Readiness

2/6

Stages with a signal

How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (12)

cervical squamous cell cancer · cervical squamous cell carcinoma · cervix squamous cell carcinoma · cervix uteri squamous cell carcinoma · squamous cell carcinoma of cervix · squamous cell carcinoma of cervix uteri · squamous cell carcinoma of the cervix · squamous cell carcinoma of the cervix uteri · squamous cell carcinoma of the uterine cervix · squamous cell carcinoma of uterine cervix · squamous cervical cancer · uterine cervix squamous cell carcinoma

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    17,441 matched papers (12,287 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPresent

    80 matched on ClinicalTrials.gov (10 recruiting in sample)

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

17,441

17,441 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

17,441 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

12,287 in the last 10 years · high confidence · 98.8th percentile (publications denominator)

Phrase hits: 17,441 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,026

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Chen Y8 papers · 2026

    Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510095, China.

    Papers in Europe PMC
  2. 02
    Huang Y7 papers · 2026

    The Department of Gynecology, Obstetrics and Gynecology Center, The First Hospital of Jilin University, Changchun 130000, China. Electronic address: 1913543386@qq.com.

    Papers in Europe PMC
  3. 03
    Li D7 papers · 2026

    Department of Biochemistry and Molecular Biology, School of Medicine, Shihezi University, Xinjiang Endemic and Ethnic Disease and Education Ministry Key Laboratory, Shihezi, Xinjiang, 832002, China.

    Papers in Europe PMC
  4. 04
    Li J7 papers · 2026

    Department of Radiotherapy Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.

    Papers in Europe PMC
  5. 05
    Wang L7 papers · 2026

    Department of Gynecological Oncology, The 1st Affiliated Hospital of Bengbu Medical University, Bengbu, China.

    Papers in Europe PMC
  6. 06
    Zhang X7 papers · 2026

    Department of Pathology, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University Chengdu, China.

    Papers in Europe PMC
  7. 07
    Zhang Y7 papers · 2026

    Department of Gynecology, Lihuili Hospital Affiliated to Ningbo University, Ningbo, Zhejiang, China.

    Papers in Europe PMC
  8. 08
    Li X6 papers · 2025

    Department of Gynecology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, Henan, People's Republic of China.

    Papers in Europe PMC
  9. 09
    Li Y6 papers · 2026

    Zhejiang Key Laboratory of Maternal and Infant Health, Women's Hospital, Zhejiang University School of Medicine, China.

    Papers in Europe PMC
  10. 10
    Zhang J6 papers · 2026

    Department of Pathology, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Shandong, China.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

80

interventional trials for this specific condition

80 interventional trials matched this specific condition name; 10 currently recruiting in our sample. 2,477 trials are registered for squamous cell carcinoma, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 27 July 2026

80 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 98.2th percentile).

high confidence · 98.2th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

80 interventional trials matched after quoted-phrase search and title/condition post-filter.

Broader category: squamous cell carcinoma

2,477

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Observational and natural-history studies

10 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

Recruiting or not-yet-recruiting

Open the complete matched search on ClinicalTrials.gov

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Squamous cell carcinoma of the cervix uteri" OR "Squamous cell carcinoma of cervix uteri" OR "Cervical squamous cell carcinoma" OR "cervical squamous cell cancer" OR "cervix squamous cell carcinoma" OR "cervix uteri squamous cell carcinoma" OR "squamous cell carcinoma of cervix" OR "squamous cell carcinoma of the cervix" OR "squamous cell carcinoma of the uterine cervix" OR "squamous cell carcinoma of uterine cervix" OR "squamous cervical cancer" OR "uterine cervix squamous cell carcinoma"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Squamous cell carcinoma of the cervix uteri" OR "Squamous cell carcinoma of cervix uteri" OR "Cervical squamous cell carcinoma" OR "cervical squamous cell cancer" OR "cervix squamous cell carcinoma" OR "cervix uteri squamous cell carcinoma" OR "squamous cell carcinoma of cervix" OR "squamous cell carcinoma of the cervix" OR "squamous cell carcinoma of the uterine cervix" OR "squamous cell carcinoma of uterine cervix" OR "squamous cervical cancer" OR "uterine cervix squamous cell carcinoma"

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 80 interventional · 10 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"squamous cell carcinoma"

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T09:38:03.099Z